炎症巨细胞的再极化进入修复阶段,准大麻素受体2:减轻肺损伤/ARDS的潜在前景

Chloe Benedict1, Jagdish Chandra Joshi2

  • 1Harrison College of Pharmacy, Auburn University, Auburn, AL, United States.

Frontiers in pharmacology
|November 24, 2025
PubMed
概括

大麻素,特别是CB2激动剂,在治疗急性肺损伤和ARDS方面表现有前途. 它们通过重编程巨细胞来抑制炎症反应,帮助从肺部损伤中恢复.